The joys of in vitro selection: Chemically dressing oligonucleotides to satiate protein targets

Current Opinion in Chemical Biology

Volumn 1, Issue 1, 1997, Pages 10-16

  Eaton, Bruce E ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPOLYMER; NUCLEOSIDE; OLIGONUCLEOTIDE; PROTEIN;

CHEMISTRY; REVIEW;

BIOPOLYMERS; NUCLEOSIDES; OLIGONUCLEOTIDES; PROTEINS;

EID: 0031151974     PISSN: 13675931     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1367-5931(97)80103-2     Document Type: Article

References (65)

1. Tuerk C, Gold L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990, 249:505-510.
2. Ellington AD, Szostak JW: In vitro selection of RNA molecules that bind specific ligands. Nature 1990, 346:818-822.
3. Kauffman SA, Macready WG: Searching for strategies for applied molecular evolution. J Theor Biol 1995, 173:427-440.
4. Levitan B, Kauffman S: Adaptive walks with noisy fitness measurements. Mol Divers 1995, 1:53-68.
5. Gold L, Polisky B, Uhlenbeck O, Yarus M: Diversity of oligonucleotide functions. Annu Rev Biochem 1995, 64:763-797. A historic account of oligonucleotide in vitro selections.
6. Uphoff, KW, Bell SD, Ellington AD: In vitro selection of aptamers: the dearth of pure reason. Curr Biol 1996, 6:281-287. A recent review of aptamers and their use both as therapeutics and as tools for molecular recognition.
7. Gold L: Oligonucleotides as research, diagnostic, and therapeutic agents. J Biol Chem 1995, 270:13581-13584. A concise review that contrasts Oligonucleotides to other combinatorial libraries and describes their potential uses.
8. Lorsch JR, Szostak JW: Chance and necessity in the selection of nucleic acid catalysts. Accounts Chem Res 1996, 29:103-110. An excellent review of the state of nucleic acid catalysts discovered by in vitro selection.
9. Kumar PKR, Ellington AD: Artificial evolution and natural ribozymes. FASEB J 1995, 9:1183-1185.
10. Lohse PA, Szostak JW: Ribozyme-catalysed amino-acid transfer reactions. Nature 1996, 381:442-444. This paper describes the first amide bond formation catalyzed by RNA and demonstrates how powerful substrate alignment by duplex formation with the selected catalytic nucleic acid can be.
11. Illangasekare M, Sanchez G, Nickles T, Yarus M: Aminoacyl-RNA synthesis catalyzed by an RNA. Science 1995, 267:643-647. The first example of ester bond formation is described as well as HPLC partitioning of RNA catalysts.
12. Tsang J, Joyce GF: Specialization of the DNA-cleaving activity of a Group I ribozyme through in vitro evolution. J Mol Biol 1996, 262:31-42. A powerful example of how in vitro evolution can be used to identify specialized ribozymes, which are perhaps superior to those found naturally.
13. Wilson C, Szostak JW: In vitro evolution of a self-alkylating ribozyme. Nature 1995, 374:777-782.
14. Wecker M, Smith D, Gold L: In vitro selection of a novel catalytic RNA: characterization of a sulfur alkylation reaction and interaction with a small peptide. RNA 1996, 2:982-994.
15. Ekland EH, Szostak JW, Bartel DP: Structurally complex and highly active RNA ligases derived from random RNA sequences. Science 1995, 269:364-370. This paper demonstrates how nucleic acid selection can identify nucleic acids catalysts that rival proteins for related chemical transformations.
16. Cuenoud B, Szostak JW: A DNA metalloenzyme with DNA ligase activity. Nature 1995, 375:611-614.
17. Burgstaller P, Famulok M: Synthetic ribozymes and the first deoxyribozyme. Angew Chem Int Ed 1995, 34:1189-1192.
18. Conn MM, Prudent JR, Schultz PG: Porphyrin metalation catalyzed by a small RNA molecule. J Am Chem Soc 1996, 118:7012-7013. An excellent example of how the transition-state analog approach, used so successfully in the catalytic antibody field, can be employed for the selection of RNA catalysts.
19. Rohatgi R, Bartel DP, Szostak JW: Kinetic and mechanistic analysis of nonenzymatic, template-directed oligonucleotide ligation. J Am Chem Soc 1996, 118:3332-3339.
20. Ekland EH, Bartel DP: RNA-catalyzed RNA polymerization using nucleoside triphosphates. Nature 1996, 382:373-376.
21. Rohatgi R, Bartel DP, Szostak JW: Nonenzymatic, template-directed ligation of oligonucleotides is a highly regioselective for the formation of 3′→5′ phosphosphodiester bonds. J Am Chem Soc 1996, 118:3340-3344.
22. Wang Y, Killian J, Hamasaki K, Rando R: RNA molecules that specifically and stoichiometrically bind aminoglycoside antibiotics with high affinities. Biochemistry 1996, 35:12338-12346. This paper describes the use of fluorescence depolarization to map aminoglycoside binding to selected aptamers.
23. Wallis MG, von Ahsen U, Schroeder R, Famulok M: A novel RNA motif for neomycin recognition. Chem Biol 1995, 2:543-552. Comprehensive characterization of aminoglycoside binding aptamers demonstrating how exquisite aptamer recognition can be for small molecules.
24. Wang Y, Rando RR: Specific binding of aminoglycoside antibiotics to RNA. Chem Biol 1995, 2:281-290.
25. Burgstaller P, Kochoyan M, Famulok M: Structural probing and damage selection of citrulline- and arginine-specific RNA aptamers identify base positions required for binding. Nucleic Acids Res 1995, 23:4769-4776.
26. Huizenga DE, Szostak JW: A DNA aptamer that binds adenosine and ATP. Biochemistry 1995, 34:656-665.
27. Lauhon CT, Szostak JW: RNA aptamers that bind flavin and nicotinamide redox cofactors. J Am Chem Soc 1995, 117:1246-1257. A remarkable demonstration of how specific aptamers to small molecules can be. NAD can be distinguished from NADH by the selected aptamers.
28. 2+. RNA 1995, 1:538-550.
29. Tao J, Frankel AD: Arginine-binding RNAs resembling TAR identified by in vitro selection. Biochemistry 1996, 35:2229-2238.
30. Conrad RC, Baskerville S, Ellington AD: In vitro selection methodologies to probe RNA function and structure. Mol Divers 1995, 1:69-78.
31. Tian Y, Adya N, Wagner S, Giam C, Green M, Ellington AD: Dissecting protein:protein interactions between transcription factors with an RNA aptamer. RNA 1995, 1:317-326. This paper provides an illustration of how aptamers can be used as molecular tools to investigate complex biological interactions.
32. Dobbelstein M, Shenk T: In vitro selection of RNA ligands for the ribosomal L22 protein associated with Epstein-Barr Virus expressed RNA by using randomized and cDNA-derived RNA libraries. J Virol 1995, 69:8027-8034.
33. O'Connell D, Koenig A, Jennings S, Hicke B, Han H, Fitzwater T, Chang Y, Varki N, Parma D, Varki A; Calcium-dependent oligonucleotide antagonists specific for L-selectin. Proc Natl Acad Sci USA 1996, 93:5883-5887. An excellent example of how selection methods can be devised to target specific binding epitopes on protein targets.
34. Green LS, Jellinek D, Bell C, Beebe LA, Feistner BD, Gill SC, Jucker FM, Janjic N: Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem Biol 1995, 2:683-695. Examples of exhaustive post-SELEX modification to improve the therapeutic potential of aptamers.
35. Ringquist S, Jones T, Snyder EE, Gibson T, Boni I, Gold L: High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites. Biochemistry 1995, 34:3640-3648.
36. Brown D, Gold L: Selection and characterization of RNAs replicated by Q replicase. Biochemistry 1995, 34:14775-14782.
37. Schneider DJ, Feigon J, Hostomsky Z, Gold L: High-affinity ssDNA inhibitors of the reverse transcriptase of type 1 human immunodeficiency virus. Biochemistry 1995, 34:9599-9610.
38. Green L, Waugh S, Binkley JP, Hostomska Z, Hostomsky Z, Tuerk C: Comprehensive chemical modification interference and nucleotide substitution analysis of an RNA pseudoknot inhibitor to HIV-1 reverse transcriptase. J Mol Biol 1995, 247:60-68.
39. Jellinek D, Green LS, Bell C, Lynott CK, Gill N, Vargeese C, Kirschenheuter G, McGee DPC, Abesinghe P, Pieken WA et al.: Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry 1995, 34:11363-11372. An example of how including modified UTP and CTP derivatives can be used for selection of serum stable aptamers.
40. Nieuwlandt D, Wecker M, Gold L: In vitro selection of RNA ligands to substance P. Biochemistry 1995, 34:5651-5659.
41. Hamm J: Characterization of antibody-binding RNAs selected from structurally constrained libraries. Nucleic Acids Res 1996, 24:2220-2227.
42. Eaton BE, Gold L, Zichi DA: Let's get specific: the relationship between specificity and affinity. Chem Biol 1995, 2:633-638. A discussion provoking review of aptamers and how their affinities and specificities seem to be correlated despite the fact that there is no theoretical basis.
43. Jensen KB, Atkinson BL, Willis MC, Koch TH, Gold L: Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands. Proc Natl Acad Sci USA 1995, 92:12220-12224. An example of how the aptamer/target interface can drive chemical reactions.
44. Eaton BE, Pieken WA: Ribonucleosides and RNA. Annu Rev Biochem 1995, 64:837-863. A review of modified ribonucleosides and RNA including examples of chemistries that impart nuclease resistance and cross-linking.
45. Ni J, Pomerantz SC, Rozenski J, Zhang Y, McCloskey JA: Interpretation of oligonucleotide mass spectra for determination of sequence using electrospray ionization and tandem mass spectrometry. Anal Chem 1996, 68:1989-1999. With some imagination this paper can serve as the basis for structural deconvolution of aptamers derived from post-SELEX combinatorial libraries.
46. Porter KW, Tomasz J, Huang F, Sood A, Ramsay-Shaw B: N7-cyanoborane-2′-deoxyguanosine 5′-triphosphate is a good substrate for DNA polymerase. Biochemistry 1995, 34:11963-11969.
47. Crouch GJ, Eaton BE: Synthesis of 2′-deoxyuridine nucleosides with appended 5-position carbonyl cross-linking groups. Nucleosides Nucleotides 1994, 13:939-944.
48. Dewey TM, Mundt A, Crouch GJ, Zyzniewski MC, Eaton BE: New uridine derivatives for use in systematic evolution of RNA ligands by exponential enrichment J Am Chem Soc 1995, 117:8474-8475. The facile synthesis of 5-position modified UTPs and testing of modified UTPs as T7 RNA polymerase substrates is described.
49. Dewey TM, Zyzniewski MC, Eaton BE: The RNA world: functional diversity in a nucleoside by carboxyamidation of uridine. Nucleosides Nucleotides 1996, 15:1611-1617. A generic methodology for the streamlined synthesis of modified uridines is described.
50. Tu C, Keane C, Eaton BE: Palladium catalysis in the synthesis of 8-position modified adenosine, 2′-deoxyadenosine and guanosine. Nucleosides Nucleotides 1995, 14:1631-1638.
51. Tu C, Keane C, Eaton BE: Carboxyamidation of purine nucleosides: new secondary 8-carboxamid-purine nucleosides. Nucleosides Nucleotides 1997, in press.
52. Sebesta DP, O'Rourke SS, Martinez RL, Pieken WA, McGee DPC: 2′-deoxy-2′-alkoxylaminouridines: novel 2′-substituted uridines prepared by intramolecular nucleophilic ring opening of 2,2′-O-anhydrouridines. Tetrahedron 1996,52:14385-14402. Stereoselective and generic methodology for the modification of the 2′-position of uridine is described.
53. McGee DPC, Sebesta DP, O'Rourke SS, Martinez RL, Jung ME, Pieken WA: Novel nucleosides via intramolecular functionalization of 2,2′-anhydrouridine derivatives. Tetrahedron Lett 1996, 37:1995-1998.
54. McGee DPC, Vaughn-Settle A, Vargeese C, Zhai Y: 2′-amino-2′-deoxyuridine via an intramolecular cyclization of a trichloroacetimidate. J Org Chem 1996, 61:781-785.
55. Limbach PA, Crain PF, McCloskey JA: Survey and summary: modified nucleosides of RNA. Nucleic Acids Res 1994, 22:2183-2196.
56. Pomerantz SC, McCloskey JA, Tarasow TM, Eaton BE: Deconvolution of oligonucleotide libraries by electrospray ionization tandem mass spectrometry. J Am Chem Soc 1997, in press.
57. Joyce GF: Ribozymes: building the RNA world. Curr Biol 1996, 6:965-967. An insightful and thought provoking discussion of the catalytic necessities of an RNA world and what remains to be proven.
58. Joyce GF: The rise and fall of the RNA world. New Biol 1991, 3:399-407.
59. James KD, Ellington AD: The search for missing links between self-replicating nucleic acids and the RNA world. Orig Life Evol Biosphere 1995, 25:515-530.
60. Ichiro H, Ellington AD: Re-creating the RNA world. Curr Biol 1995,5:1017-1022. A description of how in vitro selection of RNA can be used to interpret molecular evolution.
61. Bloch K: Some biochemical thoughts on the RNA world. Chem Biol 1996, 3:405-407.
62. Scott WG: Molecular paleontology: understanding catalytic mechanisms in the RNA world by excavating clues from a ribozyme three-dimensional structure. Biochemistry 1996, 24:604-608.
63. Kolb VM, Dworkin JP, Miller SL: Alternative bases in the RNA world: the prebiotic synthesis of urazole and its ribosides. J Mol Evol 1994, 38:549-557.
64. Robertson MP, Miller S: Prebiotic synthesis of 5-substituted uracils: a bridge between the RNA world and the DNA-protein world. Science 1995, 268:702-705. An example of a spontaneous chemistry that could have occurred in an RNA world which would lead to the modification of uracils is described.
65. Lazcano A, Miller S: The origin and early evolution of life: prebiotic chemistry, the pre-RNA world, and time. Cell 1996, 85:793-798.